Condyloma Market: By Treatment, By End User,and Geography.

Condyloma Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment (Prescription Drugs and Surgeries), By End User (Hospitals, Retail Pharmacies, and Online Pharmacies),and Region.

Condyloma Market size was valued at US$ 1,739.7 million in 2023 and is poised to grow at a significant CAGR of 5.1% from 2024-2030. Anogenital warts spurred on by the human papillomavirus (HPV) are referred to as condyloma acuminate and can affect both the male and female populations. Anogenital warts are most frequently carried on by HPV strains 6 and 11. Warts can develop anywhere near the vagina, cervix (in females), and scrotum, penis, groin, or thighs (in males). A double-stranded DNA virus called HPV is typically transmitted through intercourse.

Condyloma acuminata susceptibility is influenced by one's age, way of life, and sexual habits. Topical treatments include imiquimod cream, sinecatechins ointment, and solutions and creams containing podophyllotoxin. Other viable therapies include cryotherapy, trichloroacetic acid solution, and several surgical techniques. Following topical therapies, Condyloma acuminata has a possibility of returning. The only therapy with clearance rates close to 100% is surgical excision. Patients should be advised on available treatments, the value of follow-up visits, and safe sex procedures. With 9 to 13 percent of the world's population afflicted, HPV is the most prevalent sexually transmitted illness.

Most often, patients between the ages of 20 and 39 are impacted. Thus, with high prevalence, primarily in the young generation, the condyloma treatment market is predicted to grow in the presumption period. There are several identified risk factors for HPV infection.The likelihood of contracting an infection rises with more past sexual partners, a history of gonorrhea and chlamydia infections, smoking, and HIV infection. With around 10 million cigarettes sold worldwide and 36.9 million people living with HIV (including 1.8 million children), the chances of condyloma morbidity are to increase in the future, thus giving the thrust for the market growth. The occurrence of condyloma acuminata is challenging to predict since anogenital warts are not a disease that must be reported.

However, according to current estimates, there are 1.1 to 1.2 incidences of anogenital warts per 1000 people per year in the United States. Further, there are international level efforts by the World Health Organization to educate the population through an authoritarian level awareness campaign and eliminate sexually transmitted diseases by providing health care facilities and funds to the governments worldwide, which will drive the condyloma treatment market to flourish in the prognosticate span of the report. The major restrain for the market is the nonreporting of the disease. The disease prevalence is much higher than reported as this disease is typically nonlethal many infected patients never report it.

Condyloma Market Key Developments

  • March 2021, Verrica signed a License Agreement with Torii Pharmaceutical Co. Ltd. granting Torii an exclusive license to develop and commercialize Verricas product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102.
  • In October 2018, Novan entered partnership with Health Decisions, a specialist Contract Research Organization (CRO), and announced clinical trial Phase II data for the treatment of external genital warts (EGW).

Condyloma Market Summary

Study Period

2024– 2030

Base Year

2023

CAGR

5.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Condyloma Market Dynamics

The prevalence of diseases caused by the Human Papilloma Virus is the most common kind of sexually transmitted disease worldwide. History of gonorrhea, Smoking, multiple sexual partners, and the presence of HIV infection is the main cause of the disease to spread worldwide. Thus, with the increase in etiology of the disease in modern society, the condyloma treatment demand either in pharmacological or surgical methods or in another advanced technological way (cryotherapy) is about to multiply. Thus, the condyloma market report by Precision Business Insights picturizes the market growth in the forecast period at a constant CAGR of 5.1%.

Condyloma Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024– 2030

Market Size in 2023

US$ 1,739.7 million

Market CAGR

5.1%

By Treatment

  • Prescription Drugs
  • Surgery

By End User

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Asia
  • Latin America

Key Features of the Report

  • The condyloma market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The global condyloma market size was valued at US$ 312.6 million in 2023 and is projected to grow at a CAGR of 4.8% from 2024 to 2030.

Perrigo Company plc, Novartis AG, Merck & Co. Inc., Emblation Ltd., Verrica Pharmaceuticals, Novan, Inc., GlaxoSmithKline plc., Pfizer Inc., Mylan N.V.

Asia Pacific is the fastest-growing region for the condyloma market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Condyloma Market Introduction
2.1. Global Condyloma Market - Taxonomy
2.2. Global Condyloma Market -Definitions
2.2.1. By Treatment
2.2.2. By End User
2.2.3. By Region
3. Global Condyloma Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Condyloma Market Dynamic Factors - Impact Analysis
3.6. Global Condyloma Market - Competition Landscape
3.7. Epidemiology
4. Global Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Condyloma Market, By Treatment, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Prescription Drugs
5.1.1. Imiquimod
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Podophyllin and Podofilox
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Trichloroacetic Acid
5.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Sinecatechins
5.1.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Others
5.1.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Surgery
5.2.1. Cryotherapy
5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Electrocautery
5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Surgical Excision
5.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.2.4. Laser Treatments
5.2.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4.3. Market Opportunity Analysis
5.2.5. Others
5.2.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.5.3. Market Opportunity Analysis
6. Global Condyloma Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Retail Pharmacies
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Online Pharmacies
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Condyloma Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Region, 2024 - 2030
8. North America Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Prescription Drugs
8.1.1.1. Imiquimod
8.1.1.2. Podophyllin and Podofilox
8.1.1.3. Trichloroacetic Acid
8.1.1.4. Sinecatechins
8.1.1.5. Others
8.1.2. Surgery
8.1.2.1. Cryotherapy
8.1.2.2. Electrocautery
8.1.2.3. Surgical Excision
8.1.2.4. Laser Treatments
8.1.2.5. Others
8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030
8.5. North America Condyloma Market Dynamics - Trends
9. Europe Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Prescription Drugs
9.1.1.1. Imiquimod
9.1.1.2. Podophyllin and Podofilox
9.1.1.3. Trichloroacetic Acid
9.1.1.4. Sinecatechins
9.1.1.5. Others
9.1.2. Surgery
9.1.2.1. Cryotherapy
9.1.2.2. Electrocautery
9.1.2.3. Surgical Excision
9.1.2.4. Laser Treatments
9.1.2.5. Others
9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Europe Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030
9.5. Europe Condyloma Market Dynamics - Trends
10. Asia-Pacific Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prescription Drugs
10.1.1.1. Imiquimod
10.1.1.2. Podophyllin and Podofilox
10.1.1.3. Trichloroacetic Acid
10.1.1.4. Sinecatechins
10.1.1.5. Others
10.1.2. Surgery
10.1.2.1. Cryotherapy
10.1.2.2. Electrocautery
10.1.2.3. Surgical Excision
10.1.2.4. Laser Treatments
10.1.2.5. Others
10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospitals
10.2.2. Retail Pharmacies
10.2.3. Online Pharmacies
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030
10.5. Asia-Pacific Condyloma Market Dynamics - Trends
11. Latin America Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prescription Drugs
11.1.1.1. Imiquimod
11.1.1.2. Podophyllin and Podofilox
11.1.1.3. Trichloroacetic Acid
11.1.1.4. Sinecatechins
11.1.1.5. Others
11.1.2. Surgery
11.1.2.1. Cryotherapy
11.1.2.2. Electrocautery
11.1.2.3. Surgical Excision
11.1.2.4. Laser Treatments
11.1.2.5. Others
11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospitals
11.2.2. Retail Pharmacies
11.2.3. Online Pharmacies
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030
11.5. Latin America Condyloma Market Dynamics - Trends
12. Middle East and Africa Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prescription Drugs
12.1.1.1. Imiquimod
12.1.1.2. Podophyllin and Podofilox
12.1.1.3. Trichloroacetic Acid
12.1.1.4. Sinecatechins
12.1.1.5. Others
12.1.2. Surgery
12.1.2.1. Cryotherapy
12.1.2.2. Electrocautery
12.1.2.3. Surgical Excision
12.1.2.4. Laser Treatments
12.1.2.5. Others
12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospitals
12.2.2. Retail Pharmacies
12.2.3. Online Pharmacies
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030
12.5. MEA Condyloma Market Dynamics - Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Bausch Health Companies Inc.
13.2.2. Graceway Pharmaceuticals
13.2.3. Glenmark
13.2.4. Allergan
13.2.5. Teva Pharmaceutical Industries Ltd.
13.2.6. Perrigo Company plc
13.2.7. Novartis AG
13.2.8. Merck & Co. Inc.
13.2.9. Emblation Ltd.
13.2.10. Verrica Pharmaceuticals
13.2.11. Novan, Inc.
13.2.12. GlaxoSmithKline plc.
13.2.13. Pfizer Inc.
13.2.14. Mylan N.V.
13.2.15. Taro Pharmaceutical Industries Ltd.
13.2.16. Cipla Ltd.
13.2.17. Phio Pharmaceuticals Corp.
13.2.18. Prestige Consumer Healthcare Inc.
13.2.19. AIM ImmunoTech, Inc.
14. Research Methodology
15. Key Assumptions and Acronyms

Key Market Players

  • Bausch Health Companies Inc.
  • Graceway Pharmaceuticals
  • Glenmark
  • Allergan
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Novartis AG
  • Merck & Co. Inc.
  • Emblation Ltd.
  • Verrica Pharmaceuticals
  • Novan, Inc.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Mylan N.V.
  • Taro Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Phio Pharmaceuticals Corp.
  • Prestige Consumer Healthcare Inc.
  • AIM ImmunoTech, Inc.

Related Industry Reports